Paris, France

Florian Auger

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 2.3

ph-index = 1


Company Filing History:


Years Active: 2013-2014

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Florian Auger: Innovator in Pharmaceutical Chemistry

Introduction

Florian Auger is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 3 patents to his name, Auger continues to push the boundaries of innovation in his field.

Latest Patents

Florian Auger's latest patents include groundbreaking work on Diphenyl-pyrazolopyridine derivatives. This invention relates to a formula that can be used therapeutically for treating or preventing diseases linked to nuclear receptors such as Nurr-1, also known as NR4A2. Another significant patent involves 5-phenylpyrazolopyridine derivatives, which also focuses on therapeutic uses of these compounds. These inventions highlight Auger's commitment to advancing medical science through innovative chemical formulations.

Career Highlights

Throughout his career, Florian Auger has worked with prominent companies in the pharmaceutical industry, including Sanofi and Sanofi-Aventis. His experience in these organizations has allowed him to develop and refine his expertise in drug development and innovation.

Collaborations

Florian Auger has collaborated with notable colleagues such as Luc Even and Danielle De Peretti. These partnerships have contributed to his success and the advancement of his research.

Conclusion

Florian Auger is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in therapeutic compounds. His innovative spirit and dedication to research continue to inspire the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…